On Thursday, RBC Capital Markets adjusted its financial outlook for Eastman Chemical (NYSE:EMN), a global specialty chemical company with a market capitalization of $10.6 billion. The firm's analyst, Arun Viswanathan, revised the price target downward from $105.00 to $101.00, while maintaining a Sector Perform rating on the company's shares.
According to InvestingPro data, eight analysts have recently revised their earnings estimates downward for the upcoming period. This adjustment comes in response to a tempered demand forecast for the second half of 2025 and a slight reduction in estimated earnings for both the fourth quarter of 2024 and the full year of 2025.
Viswanathan noted that the new estimates are set at $377 million for the fourth quarter of 2024 and $1.90 billion for the full year 2025, a decrease from the previous $402 million and $1.95 billion, respectively. The price target is based on 8.5 times the firm's projected earnings for the fiscal year 2025, a multiple that remains unchanged despite the lowered expectations. Currently trading at a P/E ratio of 12.1, the stock appears attractively valued relative to its near-term earnings growth potential, as highlighted by InvestingPro's comprehensive analysis.
The analyst acknowledged Eastman Chemical's strategic shift from lower-margin commodity segments to a focus on higher-margin specialty businesses, which now account for approximately 70% of the company's portfolio. This transition is expected to bring more consistent earnings due to the nature of the specialty sectors. The company's financial health is rated as GOOD by InvestingPro, with a notable dividend yield of 3.61% and a 15-year track record of consecutive dividend increases.
Despite the overall improvement in global energy prices, which is generally positive for the chemical industry, Viswanathan cautioned that Eastman Chemical might still exhibit characteristics of a cyclical commodity chemical company, particularly if energy prices were to fall again. However, the company's strong financial position is evidenced by its healthy current ratio of 1.52 and manageable debt-to-equity ratio of 0.92.
In conclusion, Viswanathan expressed that while the current outlook is cautious, there are potential drivers for a more positive view on Eastman Chemical's stock. These include continued strong performance, the possibility of earnings growth driven by better pricing and product mix in the specialty business, and further productivity improvements.
In other recent news, Eastman Chemical has experienced significant changes in analysts' ratings and price targets. BofA Securities upgraded the company's stock from Neutral to Buy, citing solid earnings performance and good growth prospects. The firm adjusted the price target to $109.00, down from the previous $115.00. Meanwhile, Piper Sandler maintained a Neutral rating but reduced its price target to $102.00 due to expectations of slower economic growth and increased investment in recycling capabilities.
Jefferies also maintained a Buy rating on Eastman Chemical's stock but reduced the price target to $123 from the previous $140, anticipating manageable challenges and increased EBITDA contributions from the company's investments in circularity. In contrast, Citi downgraded Eastman Chemical's shares from Buy to Neutral and reduced the price target to $104, citing a balanced outlook heading into 2025.
Mizuho (NYSE:MFG) Securities reaffirmed a Neutral rating while raising the price target to $117.00 from $113.00, following a tour of Eastman Chemical's first commercial scale PET chemical recycling plant.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.